Dendreon announced updated results from pivotal Phase 3 IMPACT study demonstrating that PROVENGE® extends overall survival in men with metastatic, castrate-resistant (hormone-refractory) prostate cancer (CRPC).
(TTWO) - buy
Take-Two Interactive Software Q1 earnings beat expectations by 20 cents and company issued upside EPS guidance for Q2.
(ZUMZ) - buy
Zumiez reported February sales at stores open at least one year rose 11.2% compared to analysts consensus of an increase by only 1.2%.
(DIVX) - buy
DivX reported Q4 earnings 5 cents above consensus and issued upside guidance for Q1. Shares rose 16% in aftermarket trading.
(PETM) - buy
PetSmart reported Q4 earnings 5 cents better than consensus, revenues rose 3.4% YoY and company issued upside guidance for Q1.
(SIGM) - buy
Sigma Designs reported Q4 earnings 27 cents better than consensus and expects Q1 revenue above $60M compared to $55.6M.
(FSYS) - buy
EARNINGS PLAY: Fuel Systems Solutions expected to report earnings of 98 cents P/S vs 32 cents P/S a year ago.
(SINA) - short
Sina reported Q4 earnings of 5 cents shy of expectations. Shares fell by over 5% in aftermarket trading.
(CMTL) - short
Comtech Telecommunications sees downside FY10 EPS of $1.85-1.95 vs $2.26 consensus and sees revs of $740-760M vs $839.52M consensus. Shares fell by over 14% in aftermarket trading.
-------
Signup and get instant entry alerts for the Free Daily Stock Picks at Zantrio.com

Read zantriocom's blog in RSS
March 4, 2010
Share This